<DOC>
	<DOCNO>NCT00002656</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness chemotherapy pyrazoloacridine treat patient stage IIIB stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>Pyrazoloacridine Treating Patients With Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate antitumor activity pyrazoloacridine ( PZA ) administer 3-hour infusion patient advance non small cell lung cancer ( NSCLC ) . II . Determine qualitative quantitative toxicity PZA administer schedule . III . Determine response survival duration NSCLC patient treat PZA . OUTLINE : Single-Agent Chemotherapy . Pyrazoloacridine , PZA , NSC-366140 . PROJECTED ACCRUAL : If 2 3 response observe first 18 evaluable patient , 12 additional patient enter . Accrual expect take 5-12 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>NSC 366140</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm non small cell lung cancer ineligible high priority protocol Sputum cytology acceptable Stage IIIB/IV Must measurable evaluable disease Lesion outside prior radiotherapy field Cytologypositive pleural effusion ascites neither measurable evaluable No brain metastases CT PATIENT CHARACTERISTICS : Age : Over 18 Performance status : Zubrod 02 Life expectancy : At least 12 week Hematopoietic : Absolute granulocyte count great 2,000/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin le 2.0 mg/dL Renal : Creatinine le 1.5 mg/dL Other : No pregnant nursing woman Negative pregnancy test require fertile woman Effective contraception require fertile patient Blood/body fluid analysis within 7 day prior registration Imaging/exams tumor measurement within 28 day prior registration PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : One prior adjuvant neoadjuvant chemotherapy allow Endocrine therapy : Not specify Radiotherapy : At least 4 week since radiotherapy recover AND Progressive disease outside radiation port Surgery : Recovered prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>